Skip to content

Friday, April 23, 2021

Home
About us
Career
Contact us
Intranet
Web Mail

HIV-NAT

The HIV Netherlands Australia Thailand Research Collaboration

Search

Home
News
Studies
Publications
Training
Conference
Laboratory
Collaborators
Community Program
Link

Home
Studies
Gut microbiome and NASH in HIV

Gut microbiome and NASH in HIV

December 31, 2018

Project no.: HIV-NAT 262

Description: n/a

Post navigation

Implementation for tuberculosis preventive therapy among latent tuberculosis infection in HIV-infected individuals using novel regimen of Isoniazid/Rifapentine daily (4 weeks) compared to Isoniazid/Rifapentine weekly (12 weeks)

A randomized double-blind study comparing standard treatment versus placebo for the treatment of influenza in low risk adults

Search

Recent Posts

EID Conference 2021

World TB Day 2021: The Clock is Ticking

Summary of Publication 2020

January 31, 2021

THAI-CTU was awarded

December 14, 2020

23rd Bangkok International Symposium on HIV Medicine 2021

October 2, 2020

HIV-NAT

HIV-NAT is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, with the Kirby Institute for infection and immunity in society in Sydney, Australia, and with the Amsterdam Institute for Global Health and Development in Amsterdam, The Netherlands. Since 1996 our centre has been conducting clinical research in HIV, meeting international standards, and gaining vast experience in the coordination of multicentre trials in Thailand.

Categories

Conference (30)
News (93)
Publications (28)
Studies (202)
Training (27)

Recent Posts

EID Conference 2021

World TB Day 2021: The Clock is Ticking

Summary of Publication 2020

January 31, 2021

THAI-CTU was awarded

December 14, 2020

Copyright © 2021 HIV-NAT

Theme by: Theme Horse